York Pharma News (LSE:YRK)

Latest York Pharma News Headlines
DateTimeSource
Headline
09/01/20092:01AMUKREGCancellation - York Pharma Plc
TIDMYRK RNS Number : 2090Y AIM 01 September 2009 ? NOTICE (614) 01/09/2009 7:00am CANCELLATION OF ADMISSION OF SECURITIES TO TRADING ON AIM YORK PHARMA PLC Trading on AIM for the under-mentioned securities have been cancelled from 01/09/2009 7:00am pursuant to AIM Rule 1... More...>>
07/28/200912:52PMUKREGAppointment of Administrators
TIDMYRK RNS Number : 4387W York Pharma plc 28 July 2009 ? York Pharma plc Appointment of Administrators Further to the announcement by the Company dated 27 July 2009, it is confirmed that Andrew Poxon and John Malcolm Titley of Leonard Curtis were appointed administrators of York Pharma plc... More...>>
07/28/20099:12AMUKREGResignation of Nominated Adviser & Broker
TIDMYRK RNS Number : 4119W York Pharma plc 28 July 2009 ? York Pharma plc ("York" or the "Company") Resignation of Nominated Adviser & Broker Following the Company's announcement yesterday that it has appointed an Administrator, York announces the resignation today of Collins Stewart Europe... More...>>
07/28/20092:00AMUKREGStatement of Intention Not to Make Offer for York
TIDMYRK RNS Number : 3643W ULURU 27 July 2009 ? ULURU NEWS Contact: Company Renaat E. Van den Hooff President & CEO Terry K. Wallberg Vice President & CFO (214) 905-5145 ULURU INC. STATEMENT OF INTENTION NOT TO MAKE AN OFFER FOR YORK PHARMA, PLC. Addison, Texas, July... More...>>
07/27/20092:00AMUKREGAdministration
TIDMYRK RNS Number : 2917W York Pharma plc 27 July 2009 ? 27 July 2009 York Pharma plc ("York" or the "Company") Appointment of Administrators The Board of York today announces that it has agreed to appoint Andrew Poxon and John Malcolm Titley of Leonard Curtis, DTE House, Hollins Mount... More...>>
07/22/20091:14PMUKREGUluru Loan Update
TIDMYRK RNS Number : 1308W York Pharma plc 22 July 2009 ? York Pharma plc ("York" or the "Company") Update on Uluru Loan Repayment On 7 April 2009, York Pharma plc announced that Uluru, Inc. ("Uluru") had made available to York a US$1.0 million short term secured line of credit (the "Loan... More...>>
06/25/20094:30AMUKREGDirectorate Change
TIDMYRK RNS Number : 4850U York Pharma plc 25 June 2009 ? 25 June 2009 York Pharma plc ("York" or the "Company") Directorate change York today announces that it has mutually agreed terms for the departure of Terry Sadler, Founder and President from the Board. The Company... More...>>
06/24/200910:23AMUKREGUpdate on Merger Discussions
TIDMYRK RNS Number : 4455U York Pharma plc 24 June 2009 ? York Pharma plc ("York" or the "Company") Update on merger discussions The Board of York today announces that the discussions between the Company and ULURU Inc. ("ULURU") concerning a proposed offer ("the Offer") by ULURU for the Company... More...>>
06/17/200910:34AMUKREGHolding(s) in Company
TIDMYRK RNS Number : 0687U York Pharma plc 17 June 2009 ? +----------------------------------------------------------------------------+ | TR-1:NOTIFICATION OF MAJOR INTERESTS IN SHARES |... More...>>
05/12/200912:44PMUKREGRestructure update
TIDMYRK RNS Number : 1382S York Pharma plc 12 May 2009 ? 12 May 2009 York Pharma plc (YRK.L) ("York" or the "Company") Restructure update and divestment of French subsidiary In January 2009, York announced that its newly appointed management team was conducting a strategic review... More...>>
04/27/200910:31AMUKREGBlock Listing Return
TIDMYRK RNS Number : 2308R York Pharma plc 27 April 2009 ? York Pharma plc ("the Company") Block Listing Return +----+---------------------------------------------------------------------+ | 1. | Name of company: York Pharma plc | | |... More...>>
04/07/20094:15AMUKREGUpdate on Discussions & further Rule 2.10
TIDMYRK RNS Number : 2561Q York Pharma plc 07 April 2009 ? York Pharma Plc (the "Company") & ULURU, Inc. ("ULURU") Update on Discussions and further Rule 2.10 announcement On 31 March 2009, the Company announced that it was in discussions with two potential offerors and that one... More...>>
03/31/20098:32AMUKREGMarket update
TIDMYRK RNS Number : 8239P York Pharma plc 31 March 2009 ? York Pharma Plc (the "Company") Market update On 20 March 2009, the Board of the Company announced that it was in discussions with two potential offerors and that these discussions included the provision of the necessary short term... More...>>
03/31/20092:30AMUKREGSuspension of trading of securities on AIM
TIDMYRK RNS Number : 7656P York Pharma plc 31 March 2009 ? 31 March 2009 York Pharma Plc (the "Company") Suspension of trading of securities on AIM On 20 March 2009, the Board of the Company announced that it was in discussions with two potential offerors and that these discussions included... More...>>
03/31/20092:30AMUKREGSuspension - York Pharma plc
TIDMYRK RNS Number : 7305P AIM 31 March 2009 ? NOTICE (221) 31/03/2009 7:30am TEMPORARY SUSPENSION OF TRADING ON AIM YORK PHARMA PLC Trading on AIM for the under-mentioned securities has been temporarily suspended from 31/03/2009 7:30am pending publication of the company's... More...>>
03/30/20095:15AMUKREGRule 8.1- (York Pharma Plc)
TIDMYRK RNS Number : 6905P J.M. Finn & Co 30 March 2009 ? FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the Takeover Code) 1. KEY INFORMATION... More...>>
03/27/20095:14AMUKREGRule 8.1- (York Pharma Plc)
TIDMYRK RNS Number : 5970P J.M. Finn & Co 27 March 2009 ? FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the Takeover Code) 1. KEY INFORMATION... More...>>
03/20/20095:28AMUKREGMarket Update
TIDMYRK RNS Number : 1983P York Pharma plc 20 March 2009 ? 20 March 2009 York Pharma plc (YRK.L) ("York" or the "Company") Market Update In January 2009, York announced that its newly appointed management team were investigating options to address the Company's short term funding needs... More...>>
03/13/20096:57AMUKREGEPT Disclosure
TIDMCLST TIDMYRK DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal Collins Stewart... More...>>
03/04/20097:40AMUKREGRule 8.3- York Pharma Plc
TIDMYRK RNS Number : 3063O FIL Limited 04 March 2009 ? AVS Number: FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
42 site:2us lse yrk091123 17:28 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )